De Palma Angela, Lorusso Mariagrazia, Di Gennaro Francesco, Quercia Rosatea, Pizzuto Ondina, Garofalo Giuseppe, Fiorella Angela, Maiolino Elena, Nex Giulia, Schiavone Marcella, De Iaco Giulia, Gentile Antonia, Lastilla Gaetano, Loizzi Michele, Resta Leonardo
Section of Thoracic Surgery, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.
Division of Pathology, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.
J Thorac Dis. 2018 Sep;10(9):5318-5327. doi: 10.21037/jtd.2018.09.01.
Pulmonary and mediastinal paragangliomas are rare tumors that may have neuroendocrine activity or be non-functional, incidental, in asymptomatic patients, or causing mass effect symptoms. Although being low-grade tumors, they can display an aggressive behaviour, developing local infiltration and distant metastases. We report our experience with three endothoracic paragangliomas and a Literature review, to point out diagnostic difficulties and problems related to surgical treatment.
From 2009 to 2017, we treated 3 patients with histological diagnosis of paraganglioma: 2 pulmonary, 1 mediastinal. No one presented catecholamine-secreting syndromes; pulmonary cases were asymptomatic, while the mediastinal one had aspecific cough and dyspnea. Imaging diagnosis was based on chest computerized tomography (CT) and magnetic resonance imaging (MRI) scan. No patient had preoperative histological diagnosis. Intraoperative pathological examination was suggestive for malignancy: in pulmonary cases, wedge resection and lobectomy were performed; the middle mediastinal mass was completely removed after challenging dissection, isolation and section of numerous vascular pedicles.
Postoperative course was uneventful in all cases. No patient received adjuvant treatments. At a median follow-up of 47 months (range, 6-102 months), two patients are alive, without local or distant recurrence; one patient died 6 months after surgery, due to disease progression.
Endothoracic paragangliomas, rare and often asymptomatic tumors, are of difficult diagnosis and should be considered malignant tumors, due to the potential aggressive behaviour of cases with high mitotic index and the frequent possibility of recurrence and metastases. Surgical resection is the treatment of choice and careful intraoperative manipulation is recommended, due to the high vascularity of these tumors, to prevent complications. After complete excision, long-term prognosis is generally good. However, even after surgical removal, a close, periodical and life-long follow-up is mandatory.
肺和纵隔副神经节瘤是罕见肿瘤,可能具有神经内分泌活性,也可能无功能,在无症状患者中偶然发现,或引起占位效应症状。尽管它们是低级别肿瘤,但可表现出侵袭性,发生局部浸润和远处转移。我们报告3例胸内副神经节瘤的治疗经验并进行文献综述,以指出诊断困难及与手术治疗相关的问题。
2009年至2017年,我们治疗了3例经组织学诊断为副神经节瘤的患者:2例肺部肿瘤,1例纵隔肿瘤。无人出现儿茶酚胺分泌综合征;肺部病例无症状,而纵隔肿瘤患者有非特异性咳嗽和呼吸困难。影像学诊断基于胸部计算机断层扫描(CT)和磁共振成像(MRI)扫描。所有患者术前均未获得组织学诊断。术中病理检查提示为恶性:肺部病例行楔形切除术和肺叶切除术;经挑战性解剖、分离并切断众多血管蒂后,完整切除了中纵隔肿块。
所有病例术后病程均顺利。无人接受辅助治疗。中位随访47个月(范围6 - 102个月),2例患者存活,无局部或远处复发;1例患者术后6个月因疾病进展死亡。
胸内副神经节瘤罕见且常无症状,诊断困难,鉴于有丝分裂指数高的病例具有潜在侵袭性以及复发和转移可能性大,应视为恶性肿瘤。手术切除是首选治疗方法,鉴于这些肿瘤血管丰富,建议术中仔细操作以预防并发症。完整切除后,长期预后一般良好。然而,即使手术切除后,也必须进行密切、定期且终身的随访。